Skip to content

Effect of Clobetasol and nitroglycerin ointment on inflammation caused by venipuncture

Comparison of clobetasol with nitroglycerin ointment on prevention of superficial phlebitis in patients admitted to the man surgical ward

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013051313301N2
Enrollment
145
Registered
2013-12-02
Start date
2013-11-12
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

phlebitis. Phlebitis and thrombophlebitis of other sites

Interventions

Intervention 1: The intervention group clobetasol Ointment 0.05% ): After selecting the desired vein and disinfected with 70% Ethanol , the catheter was fixed to the skin. The distal portion of the c
Treatment - Drugs
Treatment - Other
The intervention group clobetasol Ointment 0.05% ): After selecting the desired vein and disinfected with 70% Ethanol , the catheter was fixed to the skin. The distal portion of the catheter by clobe
The intervention group Nitroglycerin Ointmentl): After selecting the desired vein and disinfected with 70% Ethanol and paste the catheter was fixed to the skin. The distal portion of the catheter by N
The control group c: After selecting the desired vein and disinfected with 70%Ethanol and paste the catheter was fixed to the skin.

Sponsors

Lorestan University of Medical Sciences,Research
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Age between 20 and 60 years ; patients with upper limb is health ; the patient will require at least 72 hours to catheter venous; The patient has no previous phlebitis at the IV insertion site ; IV placement must be used catheter ;alcohol as a disinfectant before use catheter for disinfectant; catheter intravenous is not connected heparin lock, the patient is not allergic to the medication and adhesives ; patients with acute or chronic infectious diseases ; patients with personal history of vascular disease systemic disease, diabetes , skin disease, severe anemia , glaucoma , hypotension ( systolic pressure less than 100 mm Hg ); Patients with impaired immune systems; patients not taking anticoagulant medication . Exclusion criteria : early discharge from hospital; acute infection , lack of full cooperation with investigators .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Phlebitis. Timepoint: After Intervention every 24 hours for three days. Method of measurement: check list.

Secondary

MeasureTime frame
Prevention of phlebitis. Timepoint: post and every 24 hours for three days. Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Akbari

Lorestan University of Medical Sciences

akbari.5008@yahoo.com+98 66 1620 0140

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026